SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that Stelo, the first over-the-counter ...
Researchers overcome key challenges in the mass production of enzymatic biofuel cells, paving the way for self-powered wearable sensor. (Nanowerk News) Wearable sensors are rapidly advancing, becoming ...
Millions of people with diabetes track their glucose levels daily using finger-stick devices that draw and analyze their blood. But what if they could monitor it with just a sweat sensor? That's the ...
Enzymatic biofuel cells can act as self-powered wearable biosensors by converting chemicals in body fluids into electricity; however, manufacturing challenges have prevented their widespread adoption.
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that the FDA has cleared Stelo by Dexcom ...
This figure illustrates the electrochemical wiring of a redox enzyme via a redox-active MOF, enabling efficient electron transfer. The MOF facilitates enzyme immobilization while maintaining catalytic ...
Stelo is meant for those with Type 2 diabetes as well as people who want more insight into their blood sugar levels. Here's how biosensors are growing in 2024. Jessica was a writer on the Wellness ...
Schematic of a generic biosensor architecture. The target analyte interacts with an immobilized bioreceptor layer, and the resulting molecular recognition event is translated by a physico-chemical ...
After getting the green light from the FDA back in March, Dexcom today launched its first over-the-counter wearable continuous glucose biosensor, Stelo, in the U.S. market. The device is now available ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results